Characterization of cationic albumin in minimal change nephropathy  by Ghiggeri, Gian Marco et al.
Kidney International, Vol. 32 (1987), pp. 547—553
Characterization of cationic albumin in minimal change
nephropathy
GIAN MARCO GHIGGERI, FABRIzIO GINEVRI, GIOVANNI CANDIANO, ROBERTA OLEGGINI,
FRANCESCO PERFUMO, CARLO QUEIROLO, and ROSANNA GUSMANO
Department of Internal Medicine, Hemodialysis Section, Hospital of Lavagna (GE) and Department of Nephrology, G. Gaslini Institute of
Genoa, Italy
Characterization of cationic albumin in minimal change nephropathy.
The presence of isoalbumins with a less anionic charge than the normal
protein (p1 = 4.7) is the hallmark of proteinuria in minimal change
nephropathy (MCN). Steroid—induced restoration of near normal levels
of proteinuria is characterized by the appearance in urines of isoal-
bumins with a p1 still more anionic than the normal. In our search for an
explanation for the p1 changes, we used preparative isoelectric focusing
in granulated gels to split the microheterogeneous bands obtained from
nine MCN-aff'ected children into four fractions (Al, A2, A3, A4) with
decreasing p1 from 5.8 to 4.0 and we have determined their fatty acid
content. The least anionic fraction, Al, was the most defatted, followed
by A2, A3 and A4 in which fatty acid content progressively increased,
A4 being the most fatted fraction. Accordingly, the mean content of
fatty acids in urinary albumin in proteinuric children was lower than in
both the remission phase and in normal children (2.17 0.03 vs. 20.91
0.38 and 20.94 0.39, respectively) and was lower by a factor of 4
compared to serum albumin in the same phase of the disease (2.17
0.03 vs. 8.59 1.64). Among medium and long—chain fatty acids, the
ratio between serum and urinary albumin was the highest for linoleic
acid (-'-7), followed by that of oleic acid, palmitic acid and lauric acid.
At variance in five other patients affected by non-MCN nephrotic
syndrome this ratio was for practically all FAs about 1. These data
indicate that in MCN proteinuria the isoelectric point of urinary
albumin is a function of its fatty acid content and that only partially
defatted isoalbumins (especially those with trace amount of linoleic
acid) are present in urines. They futher suggest that the inability of fatty
acids to react with cationic isoalbumins is brought about by competitive
mechanisms with one (or more) uncharged, still uncharacterized sub-
stance(s) or an inaccessibility of the fatty acid—containing pocket of the
protein.
The role of the electrical charge of circulating macromol-
ecules in determining their repulsion by the glomerular base-
ment membrane (GBM) and the consequent exclusion from the
glomerular ultrafiltrate has long been recognized [1,2], but it
took about a decade for those findings to be applied to human
pathology. The opportunity has been given by the study of
molecular features of human albumin in children affected by
minimal change nephropathy (MCN), a condition characterized
by a massive excretion into urines of abnormally—charged
albumin isoforms (with a p1 up to 6) which are only faintly
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detectable in serum [3]. The unexpected finding of the natural
occurrence of an abnormally charged protein has shed new light
on the pathogenesis of MCN, so far associated with a loss of
charge—dependent permselectivity of the GBM [4,5], and has
raised the question of whether MCN is a disease of the GBM or
whether other circulating factor(s) is(are) involved. Indeed, the
high urinary excretion of less anionic albumin may reflect a
GBM defect, but isoalbumins altered in their surface charge
may have per se a direct pathogenetic potential. Therefore their
characterization is of primary importance in the understanding
of the pathogenesis of MCN. On a biochemical ground, some
factors may be considered as the cause of the alteration of
albumin charge in MCN. On the basis of recent observations
reported by Candiano et al [6] supporting the concept that the
hydrophobic interactions of albumin with anionic ligands are
altered in nephrotic syndrome, and in view of the fact that the
main anions normally transported by albumin are fatty acids
(FA), we have considered the possibility that the urinary
albumin in MCN is defatted albumin. The data here reported
support this concept, indicating that in MCN urinary albumin p1
is a function of its FA content, and that the excretion of defatted
albumin is facilitated compared to the massively fatted homo-
logue. These findings also described unknown features of
albumin properties in MCN that open up new pathophysiolog-
ical approaches to the disease.
Methods
Patients
Eight normal children with a mean age of 8.9 (range 5 to 11
years) and nine children with a mean age of 7.9 (range 2.42 to
15.08 years) affected by nephrotic syndrome responsive to
steroid therapy were considered in this study. By the following
current diagnostic criteria the underlying renal disease was
classified as MCN: 1) high selective proteinuria (immunoglob-
ulin 0 (IgG) clearance/transferrin (Tr) clearance < 0.1); 2)
normal blood pressure and absence of hematuria; 3) normality
of routinely evaluated parameters (C3, C4, CH5O, ANA, Ra
test, HBs Ag); 4) responsiveness of proteinuria to steroid
treatment carried out in accordance with the protocol of ISKDC
[7] (prednisone 60 mg/m2/day for 4 weeks followed by 40
mg/m2/day given on 3 consecutive days out of 7 for 4 weeks).
Clinical data are reported in Table 1. Five nephrotic patients of
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Table 1. Clinical data of the 9 children affected by MCN
Pts
Age
years Sc,. mg%
Tot.S
g%
Tot.U U.Alb. STO Tot.Sc01
mg%isg/m/m
1 13 bt 0.7
at 0.7
3.3
5.0
1417
37
417
6
244
218
350
335
2 10 bt 0.6
at 0.5
3.7
5.2
5361
64
69
6
280
268
410
396
3 9.58 bt 0.4
at 0.5
3.9
5.3
5870
272
246
7
96
88
320
312
4 15.08 bt 0.8
at 0.8
5.3
6.3
8160
82
4100
9
205
190
365
352
5 7 bt 0.4
at 0.4
4.4
5.0
3636
95
1331
8
185
172
355
376
6 4.66 bt 0.4
at 0.4
4.5
5.8
1818
29
512
8
82
104
345
340
7 3.67 bt 0.5
at 0.4
4.3
5.7
1167
45
457
8
215
195
382
370
8 2.42 bt 0.4
at 0.5
5.2
5.9
1833
46
643
8
223
200
314
322
9 5.58 bt 0.5
at 0.6
5.0
6.1
3544
48
863
8
88
96
278
273
Mean± bt 0.52± 4.40± 3645.1± 959.8± 179.8± 346.6±
SEM 0.05
at 0.53±
0.05
0.23
5.59±
0.16
799.5
79.8±
25.1
411.0
7.6±
0.3
24.4
170.1±
20.5
13.0
341.8±
12.4
Abbreviations are: Scr, serum creatinine; Tot.Spr, total serum protein; Tot.U.,. total urinary protein; U.Alb., urinary albumin; STG, serum
triglycerides; Tot.S01, total serum cholesterol; bt, before therapy, at, after therapy.
mean age 36 years (range 20 to 52) with renal histological lesion
other than MCN (2 diabetes mellitus, 1 membranous nephrop-
athy, 1 lupus nephropathy) were used as controls for NS.
Serum samples were obtained in the morning after an overnight
fast (at the onset of proteinuria, before the steroid regimen was
started) and after three days of steroid—induced remission,
when proteinuria was normal. Twenty—four urine collections
were obtained at the same times.
Purification of albumin
Albumin was separated from other serum proteins by pseudo-
ligand chromatography on Affi-Gel Blue (Bio-Rad, Richmond,
California, USA) [8] with a modification of the original method
of Travis et al [9]. The gel was packed in a 1.5 X 7 cm column
equilibrated with 0.05 M Tris-HC1-0.25 M KC1, pH 7. One ml of
serum diluted in 400 ml of 0.01 Tris HC1-0.35 M NaCl, pH 7, was
applied to the column and the elution of other proteins was
carried out by washing the column with starting buffer (about 1
liter) until a value of 0 at 280 nm was reached. The same
equilibrating buffer enriched with 1.5 KC1 was used to desorb
albumin. After separation, albumin was ultrafiltered (Amicon
PM 30 membranes) with the addition of abundant volumes of
water. Regeneration of Affi-Gel Blue was achieved with 10
column volumes of 0.1 M Tris HC1-0.54 NaC1, pH 8.5, and 0.1
M acetate buffer-0.5 NaC1, pH 4.5. Albumin was in all cases
analyzed by immunoelectrophoresis according to Grabar and
Williams [10] in a 1% agarose gel.
Analytical and preparative isoelectric—focusing
Analytical ultrathin (240 m) IEF was performed on ultrathin
polyacrylamide slabs (T% = 7, C% = 4) supported by silanized
glass (coated with 0.1% methacryloxypropyltrimethoxysilane in
acetone) according to Bianchi—Bosisio et al [11]. The gels
contained 12% (vol/vol) glycerol, 1.9% (wt/vol) ampholine in
the range of 4 to 7. The course of the pH gradient was evaluated
both by reference to six marker proteins and with a surface
electrode. The gels were prerun at 500 V for one hour and run
at 13 W, 2000 V for six hours, at 10°C. The anolyte was 0.2 M
H3P04, the catholite 0.2 M NaOH; 50 p.g of proteins were
applied per lane on filter paper pads. The focused proteins were
stained with silver nitrate according to Meml, Goldman and
Vankeuren [12]. Mter fixation in 12% (wtlvol) thrichloroacetic
acid for 20 minutes, the gels were rinsed three times for 10
minutes in 10% ethanol-5% acetic acid. They were incubated
for 10 minutes with 3.4 mrt K2Cr2O7-3.2 m HNO3, then for 30
minutes in 10 m AgNO3, under uniform high—intensity illumi-
nation. The developer contained 0.28 M NaHCO3 and 2%
(vollvol) formaldehyde; 1% acetic acid was used for stopping
the reaction. The gels were allowed to dry after exhaustive
rinsing in water. Preparative isoelectric focusing in layers of
graulate gels was performed according to Frey and Radola [13].
This technique was carried out in gels containing Ultradex IEFR
(LKB, Bromma, Sweeden). The gels were suspended in dis-
tilled H20, washed with 20 volumes of H20, and mixed with 2%
carrier ampholytes (LKB) in a range between 4.0 and 6.5
(obtained by mixing 80 parts of pH 4 to 6 and 20 parts of pH 5
to 7 ampholines). Gels (1 mm thick) were obtained by spreading
the gel suspension over a glass plate with the aid of a glass rod
and then drying the gel surface with a jet of warm air, until
irregular ito 2 mm fissures appeared at the edges. Protein (20 to
100 mg) was mixed into the gel before casting. Electrode strips
were soaked with 0.1 M NaOH and 0.1 M H3P04. Focusing was
carried out at 10°C for 24 hours applying the following running
condition: 300 volts for three hours and 2000 volts for 21 hours.
Mter electrophoresis the quality of separation was checked
by printing the gels with cellulose acetate strips and staining
them with 1% Ponceau S in 10% (wt/vol) TCA. The gels with
focused proteins and carrier ampholytes were transferred into
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Table 2. FA content of the 4 fractions obtained by
of urinary albumin
preparatiye LEF
.Albumin
fraction
C16 C18:3 C18:2 C18:1 C18
nmol/nmol albumin
Al
A2
A3
A4
0.8 — —
1.9 1.1 0.5
15.2 2.5 3
25 5.1 2.3
2.1
5.3
12.1
22.3
—
0.8
—
10.t
FA are given as nmoles FA/nmole albumin.
4.7
methanol-2 propanol (100:60:5:5) for 150 minutes at a flow of
0.6 mllmin; 2) acetonitrile-H20 (100:40) for 100 minutes at a
flow of 0.6 mI/mm. Erucic acid was used as an internal
standard. For the HPLC separation a Waters system equipped
with an M45 pump, a Rheodyne injector with a 20 1d loop, a
4.0 model 420 fluorescence detector with an Excitation Filter at 365
nm, and an Emission Filter at 415 nm was used. Data were
recorded and processed with a 740 Data Module.
Other methods
Coomassie G-250 binding assay [14] as modified by Read and
Northcate [15] was used to evaluate total proteinuria and the
albumin concentration in the Affi-Gel Blue eluate. Urinary
albumin and IgG were determined by means of nephelometry
(Beckman Immunoanalyzer, Fullerton, California, USA). A
glomerular selectivity index was calculated as the ratio between
IgG clearance and Tr clearance, the latter determined by radial
immunodiffusion.
Statistical methods
One way analysis of variance and the Student's t-paired test
Extraction of fatty acids were used to calculate variance. Results are given as means
SEM.
Results
Preparative JEF of isoalbumins and their characterization
In Figure 1 (tracks a, b) the typical behaviour at IEF of
urinary albumin from an MCN-affected child is shown: track a
is urinary albumin during the proteinuric phase, track b is
urinary albumin after remission of proteinuria. The two dif-
ferent patterns, which we described in a recent paper [31, are
characterized by the presence of less anionic isobands (p1 up to
6) in the former proteinuric phase and in the latter phase by the
presence of very anionic molecules. A mixture of the two pools
we obtained from the nine children in the study was separated
by preparative IEF into four fractions named Al -A4 (Fig. 1,
track c) corresponding to isoalbumins with decreasing p1. In
Table 2 the FA composition of the four isoforms is reported: Al
is the most defatted fraction and contains only Cl6 and C18: 1,
A4 is the most fatted and contains all major FA; between the
two extremes there are two additional isoalbumins A2 and A3
which contain intermediate amounts of FA. Of the long chain
FA, C18:2 is absent in Al, while present in trace amounts in the
other fraction.
5.8p1
5.8
42
4.0
Fig. 1. Analytical isoelectric focusing of urinary albumin in the pro-
teinuric phase of a MCN affected child (a) and after steroid induced
remission of proteinuria (b). In track c is shown a schematic represen-
tation of the fractionation of a mixture of a and b, performed by
preparative IEF in granulated gels. Al, A2, A3, A4 are the four
fractions utilized for further molecular studies on the FA content of
albumin in relation to its isoelectric point.
chromatographic columns and eluted with H20. The gel—free
solution was then ultrafiltered (Amicon PM 30-membranes) to
remove carrier ampholytes, and the final concentration of
protein was determined by means of the Coomassie dye binding
assay [14,15]. The pH gradient was determined directly in the
layer with a pH glass electrode.
For the extraction of free FA from serum we adopted the
method of Bligh and Dyer [16]; 1 ml of serum was mixed with
3.3 ml of methanol and 1.65 ml of chloroform and after
centrifugation the 5 ml extract was diluted with chloroform—
water (2:1) pH 7.5 to form a biphasic system. The layer
containing chloroform was desiccated under unreactive atmo-
sphere and resuspended in ethanol. To extract FA hydrophobi-
cally bound to albumin, 4 ml of albumin solution (1 mg/mI) was
washed four times with 10 ml of chloroform—methanol (2:1).
Insoluble protein was separated by centrifugation and dis-
carded. Excess solvent was removed under unreactive atmo-
sphere and the desiccate resuspended in ethanol.
Determination of fatty acids
FA were determined as fluorescent 9-anthryldiazomethane
derivates by HPLC. The fluorescent label 9-anthraldehyde
hydrazone (ADAM) was prepared by reacting 9-anthraldehyde
with hydrazone hydrate according to the method of Nakaya,
Tomomoto and Imoto [17]. FA were derivatized by incubating
0.25 ml of FA in ethanol with 0.25 ml of ADAM solution (2
mg/mi) for three hours in the dark. Derivatized FA were
determined by means of isocratic HPLC [181 using a Fatty Acid
ColumnR (Waters, Milford, Massachusetts, USA) working at
room temperature. Mobile phases were: I) acetonitrile-H20-
A, (
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Table 3. Fatty acid content of serum albumin purified from serum of 8 normal controls, 9 MCN affected children, and 5 non-MCN nephrotic
patients
Pts. N
ClO Cl2 C14:l C14 C16
Normals 8 0.155 91.708 0.284 167.17 0.068 40.149 0.209 123.003 0.665 392.246
bt 0.224 47.047 0,442 93.949 0.228 50. 105 0.505 108. 140 1.979 423.835
MCN 9
at 0.205 65.902 0.235 77.057 0.113 36.273 0.237 81.004 1.137 382.166
non-MCN 5 ND ND ND 0.435 95.003
10.11
1.379
0.19
441.130
36.4
MCN (proteinuric
phase) vs. normals NS P < 0.02 NS P < 0.01 NS NS P < 0.05 NS P < 0.01 NS
MCN: proteinuric vs.
non-proteinuric
phase NS NS NS NS NS NS NS NS NS NS
Albumin was purified by pseudo-ligand chromatography on Affi-Gel Blue [8,9] and FA extracted from the pure protein with 4 successive washes
with chloroform—ethanol (2:1). FA were determined as 9-anthryldiazomethane derivates by HPCL [18). Content in FA was calculated as nmoles
FAlnmol albumin and as nmol FAIl ml of serum. Results are given as mean SEM. ND, not determined; bt, before therapy; at, after therapy.
Table 3. Continued
C1S:3 C18:2 C18:l C18 Tota1 FA
0.304
0.594
177.728
128.051
0.325
1.095
191.035
234.162
0.563
1.662
332.283
350.997
0.342
0.968
201.428
15.250
209.672
3.22
8.59
1895.68
1831.22
0.431
0.521
144.790
153.62
0.490
0.548
163.691
171.54
0.885
2.02
289.387
610.45
0.605
0.732
204.518
242.76
4.94
5.635
1652.76
165.89
1714.5
NS NS P < 0.05 NS P < 0.01 NS P < 0.01 NS P < 0.01 NS
NS NS NS NS NS NS NS NS P<0.0l NS
Fatty acids of serum and urinary albumin
FA of serum and urinary albumin were determined both
before and after steroid—induced remission of proteinuria by
extracting FA from the purified protein. The results were
compared to serum and urinary albumin from normal children
and from five non-MCN nephrotic patients. Values for serum
albumin FA were calculated as FA content per mole of protein,
and as FA contained in 1 ml of serum. As shown in Table 3 all
major FAs from ClO to C18 are bound to albumin in normal
conditions, and in nephrotic syndrome with a great many
differences between the two groups and between the two phases
of the disease: 1) in both groups C16 is the major FA trans-
ported by serum albumin, followed by C18: 1, C18:2, and C18;
2) considerable amounts of medium PA such as ClO, Cl2 and
C14 (which are detectable only in trace amounts in their free
form) are bound to serum albumin; 3) the amount of FA per
mole of protein is higher both in the nephrotic groups compared
to normals and in the proteinuric phase compared to remission;
4) owing to the low levels of serum albumin the content of FA
in 1 ml of serum is comparable in the three conditions (normal
children, proteinuric and non-proteinuric MCN). The differ-
ences in urines are more marked, which confirms the data
obtained by the structural analysis of single isoalbumins. In
keeping with the observation that the less anionic isoform is
more defatted compared to the normally charged one, in
proteinuric MCN-affected children the mean content (mole pet
mole) of FA bound to albumin was lower compared to serum
albumin by a factor of 4 (2.17 0.03 vs. 8.59 1.64). By
contrast, in normal children and MCN after remission of
proteinuria the FA content of urinary albumin is higher by a
factor of 5 to 6 compared to serum albumin (20.94 0.38 vs.
3.22 0.4 and 20.91 0.38 vs. 4.94 0.55). Therefore normal
urinary albumin is ten times richer in FA compared to urinary
albumin during the proteinuric phase of MCN. Finally, the FA
content of urinary albumin in non-MCN nephrotic patients was
practically the same as serum albumin.
Values for every single FA are reported in Table 4. Table 5
shows the ratios between albumin—bound FA in serum and in
urines in all subjects considered here.
Practically all FA are more concentrated in serum albumin
compared to the urinary homologue in the proteinuric phase of
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Table 4. FA content (nmol FA/nmol albumin) of urinary albumin purified from the same patients and controls as in Table 3
Pts. N ClO C12 Cl4:1 C14 C16 C18:3 C18:2 Cl8:1 C18 Total FA
Results are given as mean + SEM; bt, before therapy; at, after therapy.
Table 5. Ratio between FA content of serum and urinary albumin for
every MCN affected child during the proteinuric phase of the disease
and 5 non-MCN nephrotic patients
Pts Cl2 Cl4 Cl6 C18:3 18:2 C18:l C18
MCN group
1 3.41 4.95 4.99 2.85 7.31 4.66 4.64
2 4.03 2.31 4.62 3.55 19.08 7.02 4.71
3 2.51 2.01 2,32 2.07 4.65 3.61 1.81
4 1.19 1.14 1.46 1.72 2.41 1.30 1.24
5 3.66 11.37 6.10 6.11 8.04 8.75 2.86
6 1.82 1.60 2.71 1.86 4.22 2.90 2.56
7 2.13 4.66 4.79 4.42 11.16 5.54 8.82
8 1.41 1.47 1.52 0.82 3.0 1.72 1.18
9 1.51 1.78 2.15 1.72 3.27 2.60 2.05
Mean SEM 2.41 3.48
1.09
3.41 2.75 7.02
1.78
4.23 3.32
Non-MCN group
Mean SEM
ND ND
1.15 1.75 1.29 1.26 1.03
Results are given as mean SEM.
MCN, and C18:2 is by far the FA with the highest ratio (—P7). In
other words, this indicates that only one of seven albumin
molecules containing one molecule of C18 :2 can overcome the
renal filter and be excreted in urines. This observation supports
the data obtained by the analysis of FA after preparative
isoelectric focusing of urinary albumin where no C18 :2 was
detectable in the isoalbumin with less anionic charge. By
contrast the serumlurinary ratio for practically all FAs in five
non-MCN nephrotic patients approached the same (Table 5).
Free FA in serum in normal and MCN-affected children
In the last part of the work we evaluated the serum concen-
tration of free FA. The first question we tried to answer was
whether albumin—bound FA and free FA are analogous or
whether they represent two different pools. Analysis of the
same serum samples before and after depletion of albumin by
chromatography (Affi-Gel Blue) gave the same results, indicat-
ing that free FA obtained by extraction from human serum by
the Bligh—Dryer procedure are in fact a separate pool. The
results reported in Table 6 support this concept. In the protein-
uric phase of MCN, free FA levels are similar to those obtained
from age—matched normal children [191, but a marked fall for
each individual FA occurs in nephrotic patients after the
remission of proteinuria. This fall is statistically significant for
all FA apart from C18, in spite of there being almost no change
in the quota of FA bound to albumin.
Discussion
New insights into the mechanisms governing the process of
excretion of proteins in normal human urines have recently
been gained from the characterization of the electrical charge of
urinary albumin [20]. On the whole, the reported observations
indicate that, in physiological conditions, the electrical charge
of albumin as well as other factors such as its carbohydrate
content [21] andlor its conformation [22] are able to influence
GBM selectivity properties towards this protein. In an exten-
sion of the study [3] it has also been demonstrated that in MCN
about 40% of albuminuria is constituted by anomalously
charged albumin (p1 up to 6.1) whose excretion is privileged
compared to the normally charged homologue. We were in-
duced by these findings (that is the high anionicity in normal
conditions and the partial cationicity in MCN) to ascertain the
causes of the variation of albumin charge. Starting from bio-
chemical considerations of the influence of molecular factors on
the overall electrical equilibrium of albumin, we considered the
possibility that variations in albumin p1 were determined by
variations in the binding of small molecules, such as fatty acids,
bearing a negative charge on the albumin surface. The following
considerations supported this hypothesis: (a) albumin is the
main natural carrier of FA [23]; (b) the interaction of albumin
with FA is principally driven by non-polar interactions which
leave the carboxyl groups of FA free to introduce negative
charges [24] (and accordingly the p1 of defatted albumin is
increased up to 6.1 compared to the fatted protein [25]); and (c)
variations in albumin p1 in non-MCN nephrotic syndrome can
be induced by treating the protein with small amounts of urea,
which are able to influence the hydrophobic interactions of the
protein but not its conformational adaptation [6].
The data here reported demonstrated that the marked varia-
tion in albumin p1 from 4.0 in normal urines to 6.1 in MCN is a
function of the PA content of the albumin from about 20 to 30
moles per mole for the most anionic isoform to about 2 to 3 for
the least anionic one. By this token albuminuria in MCN brings
about a high excretion of albumin that is considerably more
defatted compared to its serum homologue; this is particularly
true for linoleic acid whose urinary albumin content compared
Normals 8 1.363 1.426 0.982 1.653 5.321 1.864 1.282 4.261 2.789 20.941
±0.382 ±0.526 ±0.181 ±0.351 ±0.382 ±0.363 ±0.140 ±0.401 ±0.281 ±0.381
bt 0.079
±0.019
0.179
±0.024
0.076
±0.026
0.165
±0.020
0.575
±0.043
0.212
±0.017
0.149
±0.017
0.387
±0.032
0.347
±0.0345
2.174
±0.026
MCN 9
at 1.468
±0.811
1.626
±0.242
1.074
±0.473
1.528
±0.278
4.863
±0.467
2.081
±0.284
1.606
±0.130
3.769
±0.354
2.898
±0.335
20.913
±0.385
non-MCN 5 ND ND ND 0.439
±0.05
1.577
±0.44
0.834
±0.16
0.494
±0.09
2.470
± 1.21
0.822
±0.15
6.636
±2.10
MCN (proteinuric phase)
vs. normals P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P <0.001 P <0.001 P <0.001 P < 0.001 P<0.001
MCN: proteinuric vs.
non-proteinuric phase P <0.001 P <0.001 P <0.001 P <0.001 P <0.001 P <0.001 P <0.001 P <0.001 P < 0.001 P <0.001
552 Ghiggeri et a!
Table 6. Serum concentration of free FA in 9 normal chiidren and 9 MCN affected patients
Pts. N
C12 C14 C16 C18:3 C18:2 C18:l C18
nmol/1 ml
Normals
bt
MCN
at
MCN (proteinuric phase)
vs. normals
MCN: proteinuric vs.
non-proteinuric phase
8
9
33,52
23.84
27.14
NS
NS
51.71
36.25
28.74
NS
NS
346.56
255.93
164.50
NS
P <0.02
89.32
68.46
45.27
NS
NS
218.39
135.29
91.20
NS
P < 0.02
591.10
419.93
221.35
NS
P <0.01
131.14
95.72
69.04
NS
NS
to the serum homologue is about 15%. At variance in five
non-MCN proteinuric patients whose urinary excretion was
unselective with respect of the electrical charge of albumin, the
ratio between the serum and urinary albumin bound FAs was
around 1, or only moderately higher as for C 18:3 =1.75. It is of
foremost interest to note that not only serum albumin from
MCN nephrotic patients was more fatted than the urinary
homologue (mean 8.59 vs. 2.17), but also contained many more
FA molecules than serum albumin from normal aged—matched
children (mean 8.59 vs. 3.22). Therefore while there is good
correlation between p1 and FA content of albumin in urines,
some discrepancies appear to occur for serum albumin in MCN
nephrotic patients, where a lot of less anionic isoalbumins were
detectable in spite of the considerably high number of FA
bound to a single albumin.
This apparent discrepancy may be reconciled by the possi-
bility that a lot of less anionic albumin isoforms in serum in
MCN are prevented from reacting with FA; these less anionic
isoforms are at the same time the main component of urinary
albumin, but the bulk of serum albumin is markedly fatted.
Where isoalbumins do not react with FA, the binding sites for
FA may perhaps be occupied by other (hitherto uncharacter-
ized) molecules either without an electrical charge or only
partially protonated at physiological pH. Indeed it has long
been known that the organic binding sites of albumin, formed
by five, non-polar side chains with two charged residues on the
side of the pocket, are unique for many substances (including
FA) and that high serum levels of many of these substances,
such as thyroxin, tryptophan, calcium ions [26—28] and others,
displace the equilibrium constant of the protein with FA
through a competitive mechanism and vice versa. This is a
central point in the study of the alteration of albumin charge in
nephrotic syndrome, since numerous naturally—occurring sub-
stances may accumulate and may represent the uncharacterized
factor displaced by treatment with a small amount of urea, as
recently hypothesized by Candiano et al [6].
Another possible explanation for the occurrence of less
anionic isoalbumins in spite of the high mean content of FA is
that the binding sites for attachment of FA to albumin are not
readily accessible owing to a steric hyndrance near by these
sites of attachment of FA. Further studies are needed to clarify
this aspect of albumin structure in MCN. Also, in consideration
of the new therapeutical approaches to proteinuna, a better
understanding could be derived from the electrical alteration of
albumin in nephrotic syndrome.
The last point which deserves further consideration is that the
concentrations of practically all free FA in serum in MCN
decreased significantly after steroid—induced remission of pro-
teinuria, while only moderate variations in serum concentra-
tions of other lipids, such as cholesterol and triglycerides, were
found (Table 1). This finding is not justified by an increase in FA
in their bound form, since they are lower in the remission phase
than during proteinuria.
This aspect warrants further study, since this quota of FA
may be incorporated into biological membranes, including
glomerular cells, and may account for the improved imperme-
ability of the GBM induced by steroid treatment. In our
opinion, this relevant, albeit speculative aspect, has so far been
underestimated.
In conclusion, these findings indicate that urinary albumin
constituting the bulk of proteinuria in MCN is considerably
more defatted compared to the serum homologue and give
reason why the p1 of urinary albumin is higher than normal one
for protein.
The altered binding of FA to albumin is to be considered the
result of an impairment of FA to reach the binding sites of the
protein or alternatively the result of a competion with other
uncharacterized substance(s) which do(es) not introduce new
charges on the protein surface. These possibilities are currently
under investigation.
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